Chan WS, Ray J, Wai EK, et al: Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence. Arch Intern Med 164:741,n2004
Chasan-Taber L, Willett WC, Manson JE, et al: Prospective study of oral contraceptives and hypertension among women in the United States. Circulation 94:483, 1996
Chen BA, Reeves MF, Hayes JL, et al: Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trial. Obstet Gynecol 116(5):1079,2010
Cheng L, Che Y, Gulmezoglu AM: Interventions for emergency contraception.
Cochrane Database Syst Rev 2:CDOOI324, 2012
Cibula 0, Gompel A, Mueck AO, et al: Hormonal contraception and risk of cancer. Hum Reprod Update 16(6):631,n2010 Ciet P, Litmanovich DE: MR safety issues particular to women. Magn Reson Imaging Clin N Am 23(1):59, 2015
Civic 0, Scholes 0, Ichikawa L, et al: Depressive symptoms in users and nonusers of depot medroxyprogesterone acetate. Contraception 61 (6):385,02000
Clark MK, Sowers M, Levy B, et al: Bone mineral density loss and recovery during 48 months in irst-time users of depot medroxyprogesterone acetate. Fertil Steril 86: 1466, 2006
Cleland K, Raymond EG, Westley E, et al: Emergency contraception review: evidence-based recommendations for clinicians. Clin Obstet Gynecol 57(4): 741,n2014
Cleland K, Zhu H, Goldstuck N, et al: he eicacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. Hum Reprod 27(7):1994, 2012
Cole JA, Norman H, Doherty M, et al: Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Obstet Gynecol 109:339,n2007
Collaborative Group on Epidemiological Studies of Ovarian Cancer, Beral V, Doll R, et al: Ovarian cancer and oral contraceptives: collaborative reanalysis of data of 45 epidemiological studies including 23,25 women with ovarian cancer and 87,303 controls. Lancet 371:303, 2008
Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 347: 1 13, 1996
Correia L, Ramos AB, Machado AI, et al: Magnetic resonance imaging and gynecological devices. Contraception 85(6):538, 2012 Cromer BA, Smith RD, Blair JM, et al: A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception. Pediatrics 94:687, 1994